Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to market Acetaminophen Injection, 1,000 mg/100 mL (10 mg/mL) single-dose vials.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to market Ketorolac Tromethamine Tablets USP, 10 mg.
Alembic Pharmaceuticals Limited today announced that it has received final approval from the USFDA for its ANDA for Doxycycline Hyclate Delayed-Release Tablets USP, 75 mg, 100 mg, 150 mg, and 200 mg.